Hepatitis E vaccine recombinant (GlaxoSmithKline/NIAID/Novavax/WRAIR)
N/A
Report date: 2023/04/25 13:50:35
Base Information
Drug NameHepatitis E vaccine recombinant (GlaxoSmithKline/NIAID/Novavax/WRAIR)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Walter Reed Army Institute Of ResearchNovavax +[4]ย
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGenelabsNovavaxWalter Reed Army Institute Of Research +[5]ย
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A